A study of inclusion complexation of liquid non-ionic surfactants, nonylphenol (NP) and nonylphenol 9 mole ethoxylate (NP9EO), with beta-cyclodextrin (beta-CD), was carried out by mass spectrometry, surface tension, and ultraviolet-visible (UV-VIS) and Fourier transform infrared (FTIR) spectroscopies. The inclusion complexation was effectuated by heating at 80 degrees C and filtration of aqueous NP+beta-CD and NP9EO+beta-CD suspensions. The mass spectrometry and surface tension measurements revealed that NP and NP9EO form inclusion complexes with beta-CD and beta-CD possesses a higher affinity for NP. These results are supported by the data from UV-VIS spectroscopic analyses that have indicated that a three times greater amount of NP is entrapped into beta-CD than NP9EO. This phenomenon has been associated with the smaller size and a higher degree of hydrophobicity of NP that favours its entrapment into beta-CD as compared to that of NP9EO. At the structural level, the data from FTIR spectroscopic study have indicated that alkyl chains of NP and NP9EO can form van der Waals interactions with the cavity of beta-CD. Moreover, NP and NP9EO seem to cause a reorganization of the intramolecular hydrogen bonds and change of the hydration of beta-CD, but did not appear to strongly interact with C-C, C-O-C, and OH groups of beta-CD. Together these results suggest that the formation of inclusion complexes by NP and NP9EO with beta-CD molecules could constitute an effective and advantageous technique to remove liquid non-ionic surfactants from wastewater due to the non-toxic character of beta-CD to humans and the environment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.watres.2009.05.010 | DOI Listing |
Alzheimers Dement
December 2024
MRC Protein Phosphorylation and Ubiquitylation Unit, Dundee, Scotland, United Kingdom.
Background: Accumulation of misfolded a-synuclein protein in intracellular inclusion bodies of dopaminergic neurons underlies the pathogenesis of synucleinopathies, which include Parkinson's Disease (PD), Dementia with Lewy Bodies (DLB) and Multiple System Atrophy (MSA). Therefore, clearance of misfolded α-synuclein from dopaminergic neurons could in principle offer a an approach for modifying synucleinopathies, which currently remain untreatable.
Method: In this study, we employ the Affinity-directed PROtein Missile (AdPROM) system consisting of the substrate receptor of the CUL2-E3 ligase complex VHL and a nanobody selectively recognising the human α-synuclein protein RESULT: We demonstrate targeted degradation of endogenous α-synuclein from human cell lines with exquisite selectivity.
Alzheimers Dement
December 2024
University of Southern California, San Diego, USA.
Background: Recruitment of demographically diverse participants into Alzheimer's disease (AD) clinical trials, encompassing both screening and randomization, remains a consistent and persistent challenge contributing to underrepresentation of certain groups. Despite the exciting prospects of identifying therapeutic interventions for biomarker-eligible, cognitively unimpaired individuals, these studies grapple with the inherent complexities of AD trials coupled with intricate and time-consuming screening processes. Addressing this the issue of underrepresentation necessitates concerted and intentional efforts that prioritize inclusivity and equitable access to enroll adults meeting study criteria, reflecting the demographic and social diversity of North America.
View Article and Find Full Text PDFBackground: Dementia, a growing health crisis, disproportionally affects persons from racial/ethnic backgrounds and individuals with comorbidities. Latelife change in cognition is complex and nonlinear, as well as differential for these individuals. These individuals are also largely underrepresented in clinical trials.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Nova Southeastern Dr. Kiran C. Patel College of Osteopathic Medicine - TBR, Clearwater, FL, USA.
Background: Research heavily suggests that brain-derived neurotrophic factor (BDNF), vital for neuronal growth and plasticity, and cholecystokinin (CCK), a satiety hormone that regulates BDNF levels, are altered in Alzheimer's Disease pathophysiology. Factors such as dysbiosis of gut microbiota and poor food habits may affect CCK and BDNF release and brain function. The objective is to evaluate the effects of dietary habits, gut microbiota, and exercise on BDNF and CCK release in Alzheimer's Disease patients.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
Background: The emergence of dementia as a global health challenge necessitates an exploration of its unique epidemiological patterns and risk factors in Sub-Saharan Africa (SSA). Amid a growing elderly population, SSA presents an intriguing paradox of lower-than-expected dementia prevalence, prompting a comprehensive review of epidemiological nuances, lifestyle risk factors, cultural influences, and protective factors. This study critically assessed the current state of dementia research in SSA, aiming to inform tailored interventions and policies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!